US Bancorp’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,082
| Closed | -$499 | – | 4249 |
|
|
2025
Q1 | $499 | Sell |
1,082
-542
| -33% | -$250 | ﹤0.01% | 4024 |
|
|
2024
Q4 | $1.2K | Buy |
+1,624
| New | +$1.2K | ﹤0.01% | 3933 |
|
|
2024
Q2 | – | Sell |
-1,200
| Closed | -$2.88K | – | 4028 |
|
|
2024
Q1 | $2.88K | Buy |
+1,200
| New | +$2.88K | ﹤0.01% | 3639 |
|
|
2018
Q4 | – | Sell |
-128
| Closed | -$1K | – | 3641 |
|
|
2018
Q3 | $1K | Hold |
128
| – | – | ﹤0.01% | 3574 |
|
|
2018
Q2 | $2K | Buy |
+128
| New | +$2K | ﹤0.01% | 3486 |
|
|
2017
Q4 | – | Sell |
-108
| Closed | -$1K | – | 3643 |
|
|
2017
Q3 | $1K | Sell |
108
-1,077
| -91% | -$9.97K | ﹤0.01% | 3497 |
|
|
2017
Q2 | $19K | Buy |
1,185
+1,021
| +623% | +$16.4K | ﹤0.01% | 2897 |
|
|
2017
Q1 | $2K | Buy |
164
+135
| +466% | +$1.65K | ﹤0.01% | 3400 |
|
|
2016
Q4 | $0 | Buy |
+29
| New | – | ﹤0.01% | 3591 |
|